To Continue or to Withhold Opioid Analgesics? An Ethical Dilemma Involving a 63-year-old Cancer Patient Who 'Broke the Pain Contract'.
Nicholas J. Lemme(Rush University Medical Center), Margaret M. Mannix(Brown University), Rachel O. Abelman(Massachusetts General Hospital), Bryan Leyva(Brown University), James M. Badger(Brown University), Young Seol(Brown University)
PubMed
October 2, 2017
Cited by 1
Related Papers
Mechanisms of Resistance to Antibody–Drug Conjugates
|Cancers|2023|135
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
|Annals of Oncology|2023|77
Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study.
|Journal of Clinical Oncology|2023|53
Antibody–Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer
|Clinical Cancer Research|2024|43
Bioinformatic Approach to the Genetics of Preeclampsia
|Obstetrics and Gynecology|2014|42